Carbapenemase-producing gram-negative Microorganisms. Where are we now? Challenges in prevention, diagnosis, detection and therapy. Thursday 4 June 2015 Royal College of Physicians, London CPD ACCREDITED Welcome Carbapenemase-producing Gram-negatives have become a major concern worldwide. Many factors, including the ease of international travel for medical tourism and migration and the importation of food products, have been responsible for introducing these microorganisms to several countries far beyond their country of origin. These organisms cause serious infections in hospitalised patients and are associated with increased mortality. Carbapenemase-producing Gram-negatives exhibit extensive drug-resistant phenotypes, complicate therapy and limit treatment options. Strict infection control measures, including active surveillance for timely detection of colonised patients, are some of the only effective ways of preventing the introduction and transmission of these bacteria in healthcare settings. This meeting will be of interest to microbiologists, infectious disease physicians, pharmacists, scientists, infection control specialists, colleagues in industry and professionals allied to the field of infection and antimicrobial chemotherapy. This meeting has generated considerable interest, even prior to the programme being fully confirmed; early booking is therefore highly recommended. Professor Dilip Nathwani OBE BSAC President Dr Brendan Healy BSAC Meetings Secretary Call for abstracts for poster presentation Abstracts are invited, in particular from junior investigators and trainees who are encouraged to attend and submit abstracts for consideration for poster presentation. Submission forms are available from the BSAC website. The deadline for receipt of poster abstract submissions is Friday 1 May 2015. Programme 0900 Registration & coffee 0950 Welcome & introductory remarks Professor Dilip Nathwani OBE, BSAC President SESSION ONE: Social and clinical impact Chair: Professor Dilip Nathwani OBE, Consultant Physician, Ninewells Hospital, Dundee 1000 Setting the Carbapenemase scene: The impact on public, political and media psyche Professor Tim Walsh, Professor of Medical Microbiology & Antimicrobial Resistance, Cardiff 1020 Invited guest lecture Carbapenamases: Global and UK Epidemiology; Now and the future Professor Neil Woodford, Head, Antimicrobial Resistance & Healthcare Associated Infections Reference Unit (AMRHAI), PHE London 1050 1115 Panel discussion SESSION TWO: Prevention, detection and screening Chair: Professor Kate Gould, Honorary Consultant Microbiologist, Newcastle upon Tyne 1145 1205 What’s new in prevention? Professor Peter Wilson, Consultant Microbiologist, UCLH NHS Foundation Trust 1225 Laboratory detection of carbapenemase-producers Professor John Perry, Clinical Scientist, Newcastle 1245 Launch of Standard Microbiological Investigation for CRE detection Dr Albert Mifsud, Chair, Bacteriology Working Group of the Standards for Microbiological Investigations 1255 Panel discussion 1315 LUNCH, EXHIBITION & POSTER VIEWING SESSION THREE: Treatment, stewardship and surveillance Chair: Dr Nick Brown, Consultant Microbiologist, Addenbrookes Hospital, Cambridge 1415 How to treat Carbapenemase: Current treatment options, strengths and pitfalls and potential role of future drugs Dr Anastasia Antoniadou, University of Athens, Greece 1445 Stewardship – is there a role for a “carbapenem sparing strategy”? Professor Dilip Nathwani OBE, Consultant Physician, Ninewells Hospital, Dundee 1505 What next? Implementation of a national surveillance system for carbapenem resistance Dr Rachel Freeman, Field Epidemiology Training Programme Fellow , PHE London 1525 Panel discussion 1545 Closing remarks Professor Dilip Nathwani OBE, BSAC President COFFEE, EXHIBITION & POSTER VIEWING Molecular resistance and diagnosis Dr Matthew Ellington, Public Health England Carbapenemase-producing Gram-negative Microorganisms. Where are we now? Challenges in prevention, diagnosis, detection and therapy. Thursday 4 June 2015, Royal College of Physicians, London REGISTRATION FORM Please complete ALL SECTIONS in BLOCK capitals Title: First name: Surname: Job Title: Department: Institute name & address: Tel: Postcode: Fax: Email: From time to time we would like to email you with information about BSAC activities which we believe will be of interest to you. This will not involve your details being passed to any third party and you can unsubscribe at any time. If you would prefer NOT to receive this information please tick the box. No, I would prefer not to receive information from the BSAC REGISTRATION FEES (inclusive of VAT) PAYMENT DETAILS (please tick) BSAC Members (NHS) £95.00 Cheque payable to BSAC enclosed BSAC Members (commercial) £180.00 Non BSAC Members (NHS) £130.00 charge to credit/debit card Trainees (BSAC Members) £45.00 (please indicate card number, expiry date and security number) Trainees (Non BSAC Members) £75.00 Students £35.00 Industry/commercial £295.00 MASTERCARD VISA SWITCH Payment in Sterling should be made to BSAC as follows: EUROCARD SECURITY NO SOLO ELECTRON ISSUE NO switch only CARD NUMBER START DATE EXPIRY DATE CARDHOLDER’S NAME CARDHOLDER’S HOME ADDRESS I authorise the use of my credit card for this purpose Signature Date CANCELLATION POLICY No refunds will be given for cancellation notified on or after Friday 8 May 2015 Please complete all sections and return to: Esme Carruthers Event Coordinator BSAC, Griffin House 53 Regent Place Birmingham B1 3NJ Tel: +44 (0) 121 236 1988 Email: ecarruthers@bsac.org.uk Website: www.bsac.org.uk
© Copyright 2024